Effects of ultrasound-assisted botulinum neurotoxin-A injection in patients with bruxism and masseter hypertrophy

Objectives: This study aims to explore effects of ultrasound-assisted injection of the botulinum neurotoxin-A (BoNT-A) on muscle thickness (MT) in patients with masseter hypertrophy. Patients and methods: Between December 2018 and December 2019, a total of 20 patients (3 males, 17 females; mean age: 28±6.9 years; range, 18 to 42 years) with bruxism who underwent BoNT-A injections were reviewed retrospectively. The patients were treated using individualized injection dosages and sites. Assessment methods included length between the tragus and the angle of the mouth, maximal bite force, and MT of the masseter muscle. Follow-up data were collected from the hospital electronic database. Results: There were 26 masseter muscles with masseter hypertrophy in 20 patients. There was a significant difference in ultrasonographic measurements of the relaxed and contracted masseter muscles between the baseline and two weeks, one month and three months after the treatment (p

___

1. Yap AU, Chua AP. Sleep bruxism: Current knowledge and contemporary management. J Conserv Dent 2016;19:383-9.

2. Katsetos CD, Bianchi MA, Jaffery F, Koutzaki S, Zarella M, Slater R. Painful unilateral temporalis muscle enlargement: Reactive masticatory muscle hypertrophy. Head Neck Pathol 2014;8:187-93.

3. Shetty N, Malaviya RK, Gupta MK. Management of unilateral masseter hypertrophy and hypertrophic scar-a case report. Case Rep Dent 2012;2012:521427.

4. Arzul L, Corre P, Khonsari RH, Mercier JM, Piot B. Asymmetric hypertrophy of the masticatory muscles. Ann Chir Plast Esthet 2012;57:286-91.

5. Kebede B, Megersa S. Idiopathic masseter muscle hypertrophy. Ethiop J Health Sci 2011;21:209-12.

6. De la Torre Canales G, Câmara-Souza MB, do Amaral CF, Garcia RC, Manfredini D. Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review. Clin Oral Investig 2017;21:727-34.

7. Awan KH. The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions - An evidence based review. Saudi Pharm J 2017;25:18-24.

8. Al-Wayli H. Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study. J Clin Exp Dent 2017;9:e112-e117.

9. Tinastepe N, Küçük BB, Oral K. Botulinum toxin for the treatment of bruxism. Cranio 2015;33:291-8.

10. Quezada-Gaon N, Wortsman X, Peñaloza O, Carrasco JE. Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects. J Cosmet Dermatol 2016;15:238-44.

11. To EW, Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001;54:197-200.

12. Pizolato RA, Gavião MB, Berretin-Felix G, Sampaio AC, Trindade Junior AS. Maximal bite force in young adults with temporomandibular disorders and bruxism. Braz Oral Res 2007;21:278-83.

13. Mäntyvaara J, Sjöholm T, Kirjavainen T, Waltimo A, Iivonen M, Kemppainen P, et al. Altered control of submaximal bite force during bruxism in humans. Eur J Appl Physiol Occup Physiol 1999;79:325-30.

14. Cosme DC, Baldisserotto SM, Canabarro Sde A, Shinkai RS. Bruxism and voluntary maximal bite force in young dentate adults. Int J Prosthodont 2005;18:328-32.

15. Dıraçoğlu D, Alptekin K, Cifter ED, Güçlü B, Karan A, Aksoy C. Relationship between maximal bite force and tooth wear in bruxist and non-bruxist individuals. Arch Oral Biol 2011;56:1569-75.

16. Dıraçoğlu D, Güçlü B, Alptekin K, Karan A, Aksoy C. Maximal bite force measurement by the “İstanbul bite force recorder”. J PMR Sci 2008;11:117-23.

17. Kim HJ, Yum KW, Lee SS, Heo MS, Seo K. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. Dermatol Surg 2003;29:484-9.

18. Kim JH, Shin JH, Kim ST, Kim CY. Effects of two different units of botulinum toxin type a evaluated by computed tomography and electromyographic measurements of human masseter muscle. Plast Reconstr Surg 2007;119:711-7.

19. Özçakar L, Kara M, Chang KV, Çarl AB, Akkaya N, Tok F, et al. Nineteen reasons why physiatrists should do musculoskeletal ultrasound: EURO-MUSCULUS/USPRM recommendations. Am J Phys Med Rehabil 2015;94:e45-9.

20. Yu CC, Chen PK, Chen YR. Botulinum toxin a for lower facial contouring: A prospective study. Aesthetic Plast Surg 2007;31:445-51.

21. Shome D, Khare S, Kapoor R. Efficacy of botulinum toxin in treating Asian Indian patients with masseter hypertrophy: A 4-year follow-up study. Plast Reconstr Surg 2019;144:390e-396e.

22. Kim KS, Byun YS, Kim YJ, Kim ST. Muscle weakness after repeated injection of botulinum toxin type A evaluated according to bite force measurement of human masseter muscle. Dermatol Surg 2009;35:1902-6.

23. Ahn KY, Kim ST. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy. Plast Reconstr Surg 2007;120:1662-6.

24. Sipahi Calis A, Colakoglu Z, Gunbay S. The use of botulinum toxin-a in the treatment of muscular temporomandibular joint disorders. J Stomatol Oral Maxillofac Surg 2019;120:322-5.

___

Turkish journal of physical medicine and rehabilitation
  • ISSN: 2587-0823
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1991

1.2b147

Sayıdaki Diğer Makaleler

Comparison of the functional and cardiovascular effects of home-based versus supervised hospital circuit training exercises in male wheelchair users with chronic paraplegia

Nur KESİKTAŞ, Erdem KAŞIKÇIOĞLU, Nurdan PAKER, Bülent BAYRAKTAR, Ayşe KARAN, Ayşegül KETENCİ, Lütfiye MÜSLÜMANOĞLU

Physiotherapy combined with therapeutic neuroscience education versus physiotherapy alone for patients with chronic low back pain: A pilot, randomized-controlled trial

Hatice GÜL, Suat EREL, Naciye Füsun TORAMAN

The effect of aquatic training on static and semi-dynamic balance of patients with chronic ischemic stroke: A randomized clinical trial

Alireza VAKILIAN, Hossein BABAEIPOUR, Mansour SAHEBOZAMANI, Fariborz MOHAMMADIPOUR

Alexithymia in ankylosing spondylitis

Deniz KARABIÇAK, Bilinç DOĞRUOZ KARATEKİN, Afitap İÇAĞASIOĞLU

Dysphagia management during COVID-19 pandemic: A review of the literature and international guidelines

Sibel EYİGÖR, Ebru UMAY

Rehabilitation cost share and cost analysis of traumatic hand injuries: Our single-center results

Merih ÖZGEN, Ayşe Merve AYDOĞAN, Ali UYGUR, Onur ARMAĞAN, Funda BERKAN, Fezan MUTLU

Staphylococcus aureus costochondritis and chest wall abscess in a COVID-19 patient treated with tocilizumab

İlkay ERGENÇ, Canan ŞANAL TOPRAK, Zekaver ODABAŞI

Effects of ultrasound-assisted botulinum neurotoxin-A injection in patients with bruxism and masseter hypertrophy

Demirhan DIRAÇOĞLU, Tuğba ŞAHBAZ, Hasan Kerem ALPTEKİN, Nalan DOĞAN

Preoperative pain neurophysiology education for lumbar radiculopathy: A randomized-controlled trial

İsmail SARAÇOĞLU, İSMAİL KAYA, İlker Deniz CİNGÖZ, HASAN EMRE AYDIN

A rare localization of tuberculosis under infliximab treatment: Testicular involvement

Mehmet NAYİMOĞLU, Banu SARIFAKIOĞLU, Kübra USTAÖMER, Murat AKGÜL, Ayşegül İSAL ARSLAN